Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular CarcinomaZhu, A. X. · Journal of Clinical Oncology · 2006

Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancerMusa, Fernanda; Pothuri, Bhavana; Blank, Stephanie V.; Ling, Huichung T.; Speyer, James L.; Curtin, John; Boyd, Leslie; Li, Xiaochun; Goldberg, Judith D.; Muggia, Franco; Tiersten, Amy · Gynecologic Oncology · 2017

34 POSTER A phase II study of the combination of bevacizumab and erlotinib in patients with patients with unresectable hepatocellular carcinomaM. Thomas; M. Lwasaki; K. Higginbotham; R. Lozano; K. Glover; J. Abbruzzese · 2006

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumorsMatthew H. Kulke; Jennifer A. Chan; Jeffrey A. Meyerhardt; Andrew X. Zhu; Thomas A. Abrams; Lawrence S. Blaszkowsky; Eileen Regan; Carolyn Sidor; Charles S. Fuchs · 2011

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung CancerTsao, A.S. · Yearbook of Oncology · 2012

Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapyYong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh Park, Se Hoon Park, Sun Young Kim, Ji Yeon Baek, Jee Hyun Kim, Keun-Wook Lee, Tae-You Kim, Tae Won Kim · 2013

Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancerVrdoljak, Eduard; Omrčen, Tomislav; Boban, Marijo; Hrabar, Andina · Anti-Cancer Drugs · 2011

ACTR-73. A PHASE II STUDY OF TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED, UNRESECTABLE GLIOBLASTOMASumrall, Ashley; Haggstrom, Daniel; Burri, Stuart; Symanowski, James · Neuro-Oncology · 2017

Therapy for Metastatic Colorectal CancerGoldberg, R. M. · The Oncologist · 2006

Overcoming Resistance to Antiangiogenic TherapiesTejpar, S.; Prenen, H.; Mazzone, M. · The Oncologist · 2012

Nodular Lymphocyte Predominant Hodgkin LymphomaLee, A. I.; LaCasce, A. S. · The Oncologist · 2009

Managing Paraneoplastic Neurological Disordersde Beukelaar, J. W. · The Oncologist · 2006

Neuroendocrine Tumors of the PancreasEhehalt, F.; Saeger, H. D.; Schmidt, C. M.; Grutzmann, R. · The Oncologist · 2009

Clinical Mimics of LymphomaBrown, J. R. · The Oncologist · 2004

Adenoviral Gene TherapyVorburger, S. A. · The Oncologist · 2002

Management of Bone MetastasesColeman, R. E. · The Oncologist · 2000